Managed a broad mandate of duties encompassing sales, marketing and business development functions, through setting country sales objectives, developing brand strategies and launching company's innovative new portfolio of brands. In-charge of the country’s performance, P&L of the different franchises, handled special projects, handled vendors and performed analysis of insights gathered locally to identify opportunities and risks in the business lifecycle.Designations Held:✔ Apr ’18 – Aug ’19: Business Unit Head – Pharmaceuticals - Middle East ✔ Jul ’18 – Aug ’19: Country Manager – UAE

Managing P&L for Gulf Specialty Medicines Franchise of Oncology, Neurology, Hematology, Ophthalmology, Pulmonology & Cardiology by leading an outperforming 5 sales & marketing management team with 19 sales force to achieve beyond the assigned strategic objectives & business results.Concurrent Responsibilities:✔ Jan '11 - Jun '15: Marketing Manager (Ophthalmology) - Gulf Region. ✔ Jan '15 - Nov '17: Marketing Manager (Oncology & Hematology) - Gulf Region.Overall Achievements:✔ Launched & led Anti-VEGF, Eylea introduction to achieve market leadership by reaching 65% market share in units sold in the Gulf market.✔ Prepared for a complete project to expand the Diabetic macular edema market to foster Eylea market share in the Gulf market place.✔ Fostered Kogenate leadership in the FVIII market achieving 68% market share in value in the Gulf market.✔ Exploited full potential of Xarelto and maintained its leadership among new oral anticoagulants market and lead in the new brand prescription with 58% market share in the Gulf market.✔ Led the successful launch of Bayer oncology franchise: Nexavar & Stivarga in their indications across Gulf.✔ Prepared and developed a market access initiative for the treatment of non-eligible cancer and hemophilic patients.✔ Exploited life cycle management tools to ensure sustainable revenue generation for Betaferon in the multiple sclerosis market place in the Gulf.✔ Managed and led the introduction of Adempas and Ventavis in the pulmonary hypertension market with successful uptake in UAE and Oman.✔ Developed & directed smart strategies for the assigned franchise with efficient P/L portfolio management.

Prepared, developed & executed assigned marketing strategies, plans, materials and programs for the specialty Franchise products: Neurology & Pulmonology across Gulf countries.